Coronavirus [COVID-19] – WHO Public Health Emergency of International Concern (PHEIC)

Milestones :: Perspectives :: Research

 

Coronavirus [COVID-19] – WHO
Public Health Emergency of International Concern (PHEIC)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

 

Weekly Epidemiological and Operational updates
Last update: 2 Jul 2021
Confirmed cases :: 188 655 968 [week ago: 185 291 530]
Confirmed deaths :: 4 067 517 [week ago 4 010 834]
Vaccine doses administered: 3 402 275 866 [week ago: 3 078 787 056

 

::::::

16 July 2021 Speech
WHO Director-General’s opening remarks at the first meeting of the working group on strengthening WHO preparedness and response to health emergencies

WHO Director-General’s opening remarks at the media briefing on COVID-19 – 15 July 2021
15 July 2021
I would especially like to express my concern and condolences over the floods that are currently affecting Germany. I offer my deep condolences to those who have lost someone they love, and my sincere hopes that those who are missing will be found soon.
Since 2020, Germany contributed close to 750 million US dollars to WHO, including more than 500 million dollars to support the COVID-19 response. Germany was also one of the main drivers behind the formation of the Access to COVID-19 Tools Accelerator last year, and we are very grateful for the further contribution of 260 million euros and 30 million vaccine doses that Minister Spahn has just announced. We will be signing the agreement under the WHO Strategic Preparedness and Response plan after today’s press conference.
As you know, the WHO Emergency Committee met yesterday and will publish its statement shortly. The Committee has expressed concern that the pandemic is being mischaracterized as coming to an end when it is nowhere near finished. It has also warned about the strong likelihood for the emergence and global spread of new and possibly more dangerous variants of concern that may be even more challenging to control.  
The Committee also expressed deep concern about the level of funding for WHO’s Strategic Preparedness and Response Plan for COVID-19, which constrains WHO’s ability to coordinate the global response to the pandemic, particularly in terms of having the flexibility we need to move at the speed this virus moves.  And the committee has called on all countries to support WHO’s call to vaccinate at least 10% of the population of every country by the end of September.

 

::::::

Statement on the eighth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
15 July 2021
…The Committee discussed key themes including:
global inequitable access to COVID-19 vaccines which is compounded by use of the available vaccines beyond SAGE recommended priority populations and the administration of booster doses while many countries do not have sufficient access to initial doses;
the need for technology transfer to enhance global vaccination production capacity,
the importance of adapting PHSM to epidemiological and socio-economic contexts and to diverse types of gatherings,
challenges posed by the lack of harmonization in documentation requirements for vaccination and recovery status for international travel,
threats posed by current and future SARS CoV-2 variants of concern, and
efforts made by some States Parties to apply a risk-management approach to religious or sports-based mass gathering events.
The Committee unanimously agreed that the COVID-19 pandemic still constitutes an extraordinary event that continues to adversely affect the health of populations around the world, poses a risk of international spread and interference with international traffic, and requires a coordinated international response. As such, the Committee concurred that the COVID-19 pandemic remains a public health emergency of international concern (PHEIC) and offered the following advice to the Director-General.
The Director-General determined that the COVID-19 pandemic continues to constitute a PHEIC. He accepted the advice of the Committee to WHO and issued the Committee’s advice to States Parties as Temporary Recommendations under the IHR…

 

::::::

Weekly operational update on COVID-19 – 12 July 2021
Overview
n this edition of the COVID-19 Weekly Operational Update, highlights of country-level actions and WHO support to countries include:
Scaling up COVID-19 vaccination in Africa
Supporting Malaysia’s COVID-19 response and emergency preparedness
Enhancing COVID-19 testing – an investment in health
Biosafety and biosecurity training in Uzbekistan
Renovation of biosafety laboratories: enabling advancements in Thailand
Donating portable pulse oximeters to Belize
2020 Progress Report of the Incident Management Support Team for COVID-19 in WHO’s Eastern Mediterranean Region
Using OpenWHO to disseminate pandemic biosafety learning materials in Angola
Preparing cities for health emergencies from all-hazards risks and WHO Partners Platform teaming up with ECHO to support the scale up and roll-out of COVID-19 vaccine doses
Progress on a subset of indicators from the SPRP 2021 Monitoring and Evaluation Framework
Updates on WHO’s financing to support countries in SPRP 2021 implementation and provision of critical supplies.

Weekly epidemiological update on COVID-19 – 13 July 2021
Overview
Globally, in the past week the number of new cases and deaths both increased when compared to the previous week. Nearly 3 million new cases of COVID-19 were reported globally and with just under 56 000 new deaths in the past week; cumulative deaths have now surpassed 4 million. All Regions apart from the Region of the Americas reported increases in new cases in the past week and the largest increase in new deaths was observed in the African Region.
In this edition, two special focuses are provided:
A synopsis of the latest WHO COVID-19 Rapid Risk Assessment, which aims to review the current status of global public health risks associated with the pandemic through an in-depth hazard, exposure and context assessment.
A short update on the geographical distribution of SARS-CoV-2 Variants of Concern (VOCs) Alpha, Beta, Gamma and Delta.